More from Investing
I'm willing to hold part of this through earnings but I'll likely shift to a call spread.
After you do your homework on the pharma, here's what the technicals say about playing it.
The charts and indicators for BBY are in good shape, but here's why I would wait.
Su stated that she expects the market for PCs to be flattish for 2022, as she insinuated a lack of concern.